You just read:

Achieve Announces Final Data from Cytisinicline Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study to be Presented at Society for Research on Nicotine & Tobacco Annual Meeting

News provided by

Achieve Life Sciences, Inc.

Feb 22, 2019, 05:30 ET